Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Douglas A. McIntyre | Jan 12, 2009 at 3:12 PM EST

Medtronic Adjusts Long-Term Goals (MDT)

Medical devices was supposed to be recession-proof, or at least was supposed to be recession-resistant. But we have seen over…

Douglas A. McIntyre | Jan 12, 2009 at 10:43 AM EST

100% Buyout Premiums Still Exist (ABT, EYE)

If we told you on Friday that a decent-sized medical merger was coming with a 100% premium, you probably wouldn’t…

Douglas A. McIntyre | Jan 6, 2009 at 5:01 PM EST

La Jolla Gets More Hope (LJPC, BMRN)

La Jolla Pharmaceutical Company (NASDAQ: LJPC) has been more than just a troubled biotech. It has even been considered an…

Douglas A. McIntyre | Jan 5, 2009 at 7:15 AM EST

Is Pfizer About To Be On Acquisition Path? (PFE, AMGN, WYE, GILD, BMY, LLY, SGP, CELG, GENZ, BIIB)

There may be some speculation that drug giant Pfizer Inc. (NYSE: PFE) is looking at expansion through acquisitions. The FT…

Douglas A. McIntyre | Dec 18, 2008 at 8:31 AM EST

Auxilium Scores on Pfizer Pact (AUXL, PFE)

Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) is responding well in pre-market trading after the company signed an overseas commercialization agreement with…

Douglas A. McIntyre | Dec 15, 2008 at 9:25 AM EST

Day Trader Alert: Biogen Idec & Another PML Case (BIIB, ELN)

Biogen Idec Inc. (NASDAQ: BIIB) just came out with an SEC filing showing that on December 11, 2008, regulatory agencies…

Douglas A. McIntyre | Dec 11, 2008 at 10:10 AM EST

Diabetes Trifecta (AMLN, LLY, ALKS)

Amylin Pharmaceuticals, Inc., (NASDAQ: AMLN) has been a battered biotech lately. But shares have just now gotten back above the…

Douglas A. McIntyre | Dec 10, 2008 at 11:04 AM EST

Short Sellers, No Direction in Biotech (AMGN, BIIB, CELG, GENZ, GILD)

It seems that short sellers have no real direction in the major NASDAQ biotech stocks from mid-November to late-November. Generally…

Douglas A. McIntyre | Dec 9, 2008 at 8:57 AM EST

Merck Bares All In Pipeline Presentation (MRK)

Merck & Co., Inc. (NYSE: MRK) today outlined its drug pipeline and has reaffirmed its guidance given last week. Merck…

Douglas A. McIntyre | Dec 5, 2008 at 11:04 AM EST

10 CEOs To Go In 2009: James Tobin of Boston Scientific (BSX)

Generally speaking, we do not like to bring CEOs back from a past "list of CEOs to go." James Tobin…

Douglas A. McIntyre | Dec 4, 2008 at 7:29 AM EST

Merck (MRK): People Won’t Even Buy Drugs

So much fore feeling better in a bad economy. Merck (MRK) offered lackluster guidance for next year and the stock…

Douglas A. McIntyre | Dec 2, 2008 at 1:56 PM EST

Can UnitedHealth Really Keep Its Targets? (UNH)

UnitedHealth Group Inc. (NYSE: UNH) has made some rather bold predictions for 2009. What is interesting here is that these…

Douglas A. McIntyre | Dec 1, 2008 at 8:21 AM EST

J&J: Now Master Over Mentor (MNT, JNJ)

If you thought that high-premium buyouts or M&A was dead, that is not the case in at least some opportunities. …

Douglas A. McIntyre | Nov 25, 2008 at 4:53 PM EST

ZymoGentics Backers File To Sell Stock (ZGEN, NVO)

ZymoGenetics, Inc. (NASDAQ: ZGEN) has filed an SEC registration which would allow the company to sell up to $100 million…

Douglas A. McIntyre | Nov 25, 2008 at 4:39 PM EST

Arena Raising R&D Funds (ARNA)

Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) has filed to sell up to 25 million shares of common stock in a public…

1 … 344 345 346 347 348 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Medtronic Adjusts Long-Term Goals (MDT)

100% Buyout Premiums Still Exist (ABT, EYE)

La Jolla Gets More Hope (LJPC, BMRN)

Is Pfizer About To Be On Acquisition Path? (PFE, AMGN, WYE, GILD, BMY, LLY, SGP, CELG, GENZ, BIIB)

Auxilium Scores on Pfizer Pact (AUXL, PFE)

Day Trader Alert: Biogen Idec & Another PML Case (BIIB, ELN)

Diabetes Trifecta (AMLN, LLY, ALKS)

Short Sellers, No Direction in Biotech (AMGN, BIIB, CELG, GENZ, GILD)

Merck Bares All In Pipeline Presentation (MRK)

10 CEOs To Go In 2009: James Tobin of Boston Scientific (BSX)

Merck (MRK): People Won’t Even Buy Drugs

Can UnitedHealth Really Keep Its Targets? (UNH)

J&J: Now Master Over Mentor (MNT, JNJ)

ZymoGentics Backers File To Sell Stock (ZGEN, NVO)

Arena Raising R&D Funds (ARNA)

Data Center Expert Warns Gigawatt-Scale AI Buildouts Could Trigger Rolling Blackouts

Jim Cramer on Applied Digital: A $7.5 Billion Contract Isn’t Enough Without Profits

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up

At 59, Tapping a $1.5 Million 401(k) First Could Trigger $55,000 in Penalties and Taxes

Data Center Expert Warns Gigawatt-Scale AI Buildouts Could Trigger Rolling Blackouts

Jim Cramer on Applied Digital: A $7.5 Billion Contract Isn’t Enough Without Profits

Health and Healthcare Articles

All Health and Healthcare Articles

Medtronic Adjusts Long-Term Goals (MDT)

100% Buyout Premiums Still Exist (ABT, EYE)

La Jolla Gets More Hope (LJPC, BMRN)

Is Pfizer About To Be On Acquisition Path? (PFE, AMGN, WYE, GILD, BMY, LLY, SGP, CELG, GENZ, BIIB)

Auxilium Scores on Pfizer Pact (AUXL, PFE)

Day Trader Alert: Biogen Idec & Another PML Case (BIIB, ELN)

Diabetes Trifecta (AMLN, LLY, ALKS)

Short Sellers, No Direction in Biotech (AMGN, BIIB, CELG, GENZ, GILD)

Merck Bares All In Pipeline Presentation (MRK)

10 CEOs To Go In 2009: James Tobin of Boston Scientific (BSX)

Merck (MRK): People Won’t Even Buy Drugs

Can UnitedHealth Really Keep Its Targets? (UNH)

J&J: Now Master Over Mentor (MNT, JNJ)

ZymoGentics Backers File To Sell Stock (ZGEN, NVO)

Arena Raising R&D Funds (ARNA)

Data Center Expert Warns Gigawatt-Scale AI Buildouts Could Trigger Rolling Blackouts

Jim Cramer on Applied Digital: A $7.5 Billion Contract Isn’t Enough Without Profits

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up

Featured Reads

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up

At 59, Tapping a $1.5 Million 401(k) First Could Trigger $55,000 in Penalties and Taxes